22. Moyamoya disease Clinical trials / Disease details


Clinical trials : 14 Drugs : 21 - (DrugBank : 14) / Drug target genes : 28 - Drug target pathways : 44

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs031200402
23/04/202108/03/2021Search for abnormalities of fundus blood vessels in moyamoya diseaseSearch for abnormalities of fundus blood vessels in moyamoya disease Moyamoya disease
Moyamoya disease
For fluorescein fundus angiography, 500 mg of fluorescein (5 ml vial of aqueous solution containing 500 mg of fluorescein) and 25 mg of Ophthagreen (2 ml of blue indocyanine green) are dissolved in 2 ml of distilled water for injection and injected through the forearm of the elbow vein. In daily practice, diabetic retinopathy can be treated by using a diabetic retinal imaging system (optos). In daily practice, it is used for the diagnosis of diabetic retinopathy, uveitis, occlusive retinal vascular disease, and age-related macular degeneration.Akiyama HideoNULLRecruiting>= 20age oldNot applicableBoth50N/AJapan